Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Blood Research|May 3, 2021
Novel combination immunochemotherapy beyond CD20 for B-cell lymphomasJun Ho YiSeminars in Hematology|December 14, 2025
Targeting B-cell maturation antigen in relapsed or refractory multiple myeloma: On the verge of its prime timeJun Ho Yi, Dok Hyun Yoon, Kihyun KimF1000Research|December 21, 2017
Recent advances in understanding and managing T-cell lymphomaJun Ho Yi, Seok Jin Kim, Won Seog KimBlood Research|January 16, 2018
Brentuximab vedotin: clinical updates and practical guidanceJun Ho Yi, Seok Jin Kim, Won Seog KimCancer Research and Treatment|August 20, 2024
Nivolumab in Relapsed or Refractory Primary Central Nervous System Lymphoma: Multicenter, Retrospective StudyJun Ho Yi, Seok Jin Kim, Sang-A Kim, et al.Cytokine|October 18, 2018
Profiles of serum cytokines and their clinical implications in patients with peripheral T-cell lymphomaJun Ho Yi, Kyung Ju Ryu, Young Hyeh Ko, et al.Blood Research|November 21, 2025
Brentuximab vedotin combined with cisplatin, cytarabine, and dexamethasone treatment in transplant-eligible Korean patients with relapsed or refractory Hodgkin's lymphomaJun Ho Yi, Young Hoon Park, Myung-Won Lee, et al.Hematological Oncology|July 14, 2009
18F-FDG uptake and its clinical relevance in primary gastric lymphomaJun Ho Yi, Seok Jin Kim, Joon Young Choi, et al.Medical Oncology (Northwood, London, England)|June 11, 2008
Rituximab-induced acute thrombocytopenia: a case report and review of the literatureJun Ho Yi, Seok Jin Kim, Hee Kyung Ahn, et al.Cytokine|March 6, 2020
Pre-treatment serum IL-10 predicts the risk of secondary central nervous system involvement in patients with diffuse large B-cell lymphomaJun Ho Yi, Sang Eun Yoon, Kyung Ju Ryu, et al.Pageof 7